![](../images/chemdb_main_product.jpg) |
![](../images/title_product_content.gif) |
|
|
|
Cefotaxime Sodium |
![](../images/col_chem_composition.gif) |
C16H16N5O7S2 Na |
![](../images/col_cas.gif) |
64485-93-4 |
![](../images/col_uses.gif) |
Name: Cefotaxime Sodium CAS Number: 64485-93-4 Molecular Formula: C16H16N5O7S2 Na Molecular Weight: 477. 48 Solubility: H2O: aqueous solutions of 4. 3-6. 2 are stable up to 3 weeks at 2-8 ¡ÆC. soluble Details Appearance: white to yellow powder ? Hazard Properties: A solid. Mp: 162– 163¡Æ (decomp). Indications and Usage £ºTreatment of infections of lower respiratory tract including pneumonia, urinary tract, skin and skin structures, bone and joints treatment of bacteremia/septicemia, CNS infections, intra-abdominal infections including peritonitis, gynecological infections including pelvic inflammatory disease, endometritis and pelvic cellulitis caused by susceptible strains of specific microorganisms perioperative prophylaxis.
|
![](../images/col_property.gif) |
Name: Cefotaxime Sodium CAS Number: 64485-93-4 Molecular Formula: C16H16N5O7S2 Na Molecular Weight: 477. 48 Solubility: H2O: aqueous solutions of 4. 3-6. 2 are stable up to 3 weeks at 2-8 ¡ÆC. soluble Details Appearance: white to yellow powder ? Hazard Properties: A solid. Mp: 162– 163¡Æ (decomp). Indications and Usage £ºTreatment of infections of lower respiratory tract including pneumonia, urinary tract, skin and skin structures, bone and joints treatment of bacteremia/septicemia, CNS infections, intra-abdominal infections including peritonitis, gynecological infections including pelvic inflammatory disease, endometritis and pelvic cellulitis caused by susceptible strains of specific microorganisms perioperative prophylaxis.
|
Industrial field |
pharmaceutical |
|
|
![](../images/product_title_com.gif) |
|
|
|
![](../images/box_com_top2.gif) |
There are no existing companies to distribute selected chemical product |
|
![](../images/box_com_bottom.gif) |
|
|
|